Goldenwell Biotech, Inc.
GWLL· OTC
GWLLGoldenwell Biotech, Inc.
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001477932-22-006072
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $3.71K | $1.11K | — |
| Net Income | -$26.80K | -$23.58K | -$141.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Goldenwell Biotech, Inc. · CIK 1800373 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end
